Divis Laboratories Ltd | DIVI - Net Income

Stock Price
5,989.50
Daily Change
-65.00 -1.07%
Monthly
-9.83%
Yearly
-2.13%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR6.89B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Aurobindo Pharma INR 8.48B 237M Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 331M 65M Sep/2025
Lupin INR 14.78B 2.59B Sep/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025